Remote Neuromodulation: A New Hope for Pediatric Migraines
- MigraineMind
- Nov 28, 2025
- 1 min read
Research Summary
A preliminary study published in the journal Children (Basel) explored the real-world use of the FDA-cleared Nerivio device for remote electrical neuromodulation (REN) in managing pediatric migraines. Involving 24 patients aged 10-18, mostly female, the study found that Nerivio stopped headaches in 33% of participants and shortened them in 50%, while 42% reported using less medication. Functional improvements included a 23% reduction in limited-activity days. Preferences leaned towards Nerivio, with 83% wishing to continue its use, and only 13% experiencing mild discomfort. These findings suggest REN could be a promising non-drug option for pediatric migraine management, warranting further research.
Study Details
👥 Research Team: Blumovich A et al.
📚 Published In: Children (Basel)
📅 Publication Date: 2025 Nov 5
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.